● CLOSED
S&P 500769.35
-1.75 (-0.23%)
|
AAPL319.70
+5.12 (+1.63%)
|
MSFT513.53
+8.47 (+1.68%)
|
TSLA348.75
-6.06 (-1.71%)
|
NVDA217.55
-10.43 (-4.57%)
|
AMZN266.43
+10.17 (+3.97%)
|
GOOGL346.59
+5.94 (+1.74%)
|
META578.02
+6.92 (+1.21%)
|
BTC77,816
-30.34 (-0.04%)
|
GOLD4,459
+2.38 (+0.05%)
|
OIL90.75
-0.21 (-0.23%)
|
10Y3.86
-0.02 (-0.52%)
|
S&P 500769.35
-1.75 (-0.23%)
|
AAPL319.70
+5.12 (+1.63%)
|
MSFT513.53
+8.47 (+1.68%)
|
TSLA348.75
-6.06 (-1.71%)
|
NVDA217.55
-10.43 (-4.57%)
|
AMZN266.43
+10.17 (+3.97%)
|
GOOGL346.59
+5.94 (+1.74%)
|
META578.02
+6.92 (+1.21%)
|
BTC77,816
-30.34 (-0.04%)
|
GOLD4,459
+2.38 (+0.05%)
|
OIL90.75
-0.21 (-0.23%)
|
10Y3.86
-0.02 (-0.52%)
|
Invest Daily
ACTIVO AHORA

Únete al Debate de $LLY

Inversores reales compartiendo análisis en tiempo real

5
Publicaciones
1
Inversores
Pulso de la Comunidad
Alcista 40%20% Bajista
Ver Todos los Hilos

Gratis · Sin tarjeta de crédito

L

$LLY

Eli Lilly

5 publicaciones · debate comunitario gratuito

GráficosInvestigación IAValor JustoTodos los hilos
🐂 Alcista 40%Sentimiento de la Comunidad20% 🐻 Bajista

Únete al debate de LLY - es gratis

5 publicaciones · $LLY

T
theDave😐 Neutral37d

@biotech_bull_88 75x forward earnings. competition coming from novo and pfizer. the growth is real but the multiple leaves zero room for error. one bad trial result and this drops 30%

D
diamondHands🐻 Bajista37d

everyone is bullish on glp1. when everyone is bullish thats when i get nervous. the obesity space will be commoditized in 3 years. orforglipron is oral and cheaper

H
humble_lurker_1🐂 Alcista37d

mounjaro and zepbound are literally printing money. the glp1 market is maybe 100B in a few years. lilly has the best molecules. the pipeline with next gen obesity drugs is even better

G
GnstitutionalFhale😐 Neutral37d

Trading at 75x forward earnings. The GLP-1 growth is real but competition is coming from Novo Nordisk and Pfizer. The multiple leaves no room for error.

M
mattw🐂 Alcista37d

Mounjaro and Zepbound are printing money. The GLP-1 market is enormous and Lilly has the best molecules. The pipeline with next gen obesity drugs is even better.

Desbloquear Análisis Institucional de $LLY

Valor justo con IA, inteligencia de ganancias, señales de rotación sectorial y más.

Keep Reading

market analysis

The Consumer Is Not Fine: What Walmart, Target, Lowe's, Home Depot, Best Buy and the Value Chains Are Quietly Telling Us About Household Stress

Read article value investing

Return on Invested Capital: The Hidden Scorecard That Identifies Great Businesses From Mediocre Ones

Read article advanced strategies

Private Credit's $41 Trillion Expansion: The Most Dangerous Opportunity in Finance Right Now

Read article real estate

The Great Housing Reset of 2026: Why the American Dream Is Being Repriced and What to Do About It

Read article